Researchers link death in gene-editing study to a virus used to deliver the treatment, not CRISPR

The lone volunteer in a gene-editing study targeting a rare form of Duchenne muscular dystrophy likely died after having a reaction to the virus that delivered the therapy in his body, researchers concluded in an early study.Terry Horgan, 27, of Montour F